Copyright
©The Author(s) 2024.
World J Nephrol. Dec 25, 2024; 13(4): 98709
Published online Dec 25, 2024. doi: 10.5527/wjn.v13.i4.98709
Published online Dec 25, 2024. doi: 10.5527/wjn.v13.i4.98709
Ref. | Published date | Ancestry | GWAS population | Genome-wide significant loci (candidate gene) |
Susceptibility to IgA nephropathy | ||||
Feehally et al[12] | 2010 | European ancestry | 244 cases and 4980 healthy controls | 6p21 (HLA) |
Gharavi et al[4] | 2011 | Chinese and European ancestry | 3144 cases and 2822 healthy controls | 6p21 (HL-DQB1/DRB1; PSMB9/TAPI; HLA-DPA1/DPB2), 1q32 (CFHR3/R1), 22q12 (HORMAD2) |
Yu et al[13] | 2011 | Chinese ancestry | 1434 cases and 4270 healthy controls | 6p21 (HLA), 8p23 (DEFAs), 17p13 (TNFSF13), 22q12 (MTMR3) |
Kiryluk et al[14] | 2014 | European and East Asian ancestry | 7658 cases and 12954 healthy controls | 6p21 (HLA-DQ-HLA-DR; TAP1-PSMB8; HLA-DP), 1p13 (VAV3), 1q32 (CFHR3-CFHR1 deletion), 8p23 (DEFAs), 9q34 (CARD9), 16p11 (ITGAM-ITGAX), 17p13 (TNFSF13), 22q12 (HORMAD2) |
Li et al[15] | 2015 | Chinese ancestry | 1434 cases and 10661 healthy controls | 6p21 (HLA), 3q27 (ST6GAL1), 8p23 (DEFA), 8q22 (ODF1-KLF10), 11p11 (ACCS), 16p11 (ITGAX-ITGAM, 22q12 (HORMAD2) |
Jeong et al[16] | 2019 | Korean ancestry | 188 cases and 455 healthy controls | 10p15 (ANKRD16) |
Li et al[17] | 2020 | Chinese and European ancestry | 2628 cases and 11563 healthy controls | 6p21 (HLA), 1q23 (FCRL3), 1p36 (PAD14), 6p25 (DUSP22/IRF4), 8p23 (DEFA), 16p11 (ITGAX-ITGAM), 17p13 (TNPSF12-TNPSF13), 22q12 (MTMR3/HORMAD2) |
Zhou et al[18] | 2021 | Chinese ancestry | 601 cases and 4076 healthy controls | 6p21 (GABBR1), suggestive genes (TGFB1, CCR6, STAT3, CFB) |
Li et al[19] | 2023 | Chinese ancestry | 2378 cases and 15642 healthy controls | 6p21 (HLA), 6p21.1 (VEGFA), 16q22.2 (PKD1 L3), 17p13 (TNFSF13) |
Kiryluk et al[20] | 2023 | European and East Asian ancestry | 10146 cases and 28751 healthy controls | 6p21 (HLA), 8 known non-HLA loci (CFH, FCRL3, IRF4/DUSP22, DEFA ¼, CARD9, ITGAM/ITGAX, TNFSF 13/12, MTMR3/HORMAD2/LIF/OSM), 16 new non HLA loci (TNFSF4/18, CD28, REL, PF4V1, LY86, LYN, ANXA13, TNFSF8/15, ZMIZ1, REEP3, OVOL1/RELA, ETS1, IGH, IRF8, TnFRSF13B, and FCAR) CCR6 (only in the East Asian cohorts) |
Serum Gd-IgA1 levels | ||||
Gale et al[21] | 2017 | European and Chinese ancestry | 513 subsets | 7p21 (C1GALT1) |
Kiryluk et al[22] | 2017 | European and East Asian ancestry | 2633 subsets | 7p21 (C1GALT1), Xq24 (C1GALT1C1) |
Wang et al[23] | 2021 | Chinese ancestry | 1127 patients with IgAN | 7p22 (C1GALT1), 9q22 (GALNT12) |
- Citation: Salvadori M, Rosso G. What is new in the pathogenesis and treatment of IgA glomerulonephritis. World J Nephrol 2024; 13(4): 98709
- URL: https://www.wjgnet.com/2220-6124/full/v13/i4/98709.htm
- DOI: https://dx.doi.org/10.5527/wjn.v13.i4.98709